Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to reduce airway glucose in stable COPD
2018-001755-12Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Mean sputum glucose concentration. Status: unknown.
02
Drugs
metformin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2018-001755-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001755-12.